Form 4: Biora Therapeutics CFO Eric d'Esparbes Reports Tax-Related Stock Disposal

Eric d'Esparbes, CFO of Biora Therapeutics, reports the disposal of 27,830 shares of common stock to cover tax obligations related to vested restricted stock units.

Summary

• On August 15, 2024, Eric d'Esparbes, the Chief Financial Officer of Biora Therapeutics, Inc. (BIOR), disposed of 27,830 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units.
• The shares were disposed of at a price of $0.67 per share.
• Following the transaction, d'Esparbes directly owns 575,832 shares of Biora Therapeutics common stock.

Sentiment

Score: 5

Explanation: This is a neutral event related to tax obligations. It doesn't indicate positive or negative sentiment towards the company's prospects.

Industry Context

This filing is a routine disclosure related to executive compensation and tax obligations. It doesn't necessarily reflect a change in the executive's outlook on the company.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.

Key Dates

Keywords

Form 4, Biora Therapeutics, BIOR, Eric d'Esparbes, CFO, Stock Disposal, Tax Withholding, Restricted Stock Units, Beneficial Ownership